Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis.

Details

Language :

English

ISSN :

21522650

Volume :

21

Issue :

3

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

148863256

Full Text :

https://doi.org/10.1016/j.clml.2020.12.013